Logo

On the Mend or Grasping at Straws?

Aug 13, 2009

At Patent Docs, Donald Zuhn says that biotech/pharma IPOs and venture funding are bouncing back. In particular, he points to Cumberland Pharmaceuticals and Seattle Genetics, which are now or soon will be (respectively) trading their common stock, and to
Inspire Pharmaceuticals' announcement of a filing with the Securities and Exchange Commission to offer its stock publicly. For venture funding, Zhun says that there has been a 72 percent increase in biopharmaceutical investing between the first and second quarters of this year.

Breaking News
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.